Volitionrx (VNRX) Cash from Investing Activities (2011 - 2025)
Volitionrx's (VNRX) quarterly Cash from Investing Activities came in at -$10967.0 in Q4 2025, up 94.46% YoY from -$5639.8 in Q4 2024, and up 85.72% on a QoQ basis from -$76783.0 in Q2 2025.
Volitionrx (VNRX) Cash from Investing Activities (2011 - 2025) Analysis & Trends
Volitionrx (VNRX) has 15 years of Cash from Investing Activities data on file, last reported at -$10967.0 in Q4 2025.
- Quarterly Cash from Investing Activities rose 94.46% year-over-year to -$10967.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$89558.0 (up 84.39% YoY) and the FY2025 annual result came in at -$89558.0, up 84.39% from the prior year.
- Cash from Investing Activities climbed to -$10967.0 in Q4 2025, from -$76783.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$1808.0 in Q1 2025 to a low of -$578752.0 in Q4 2022.
- A 5-year average of -$225836.8 and a median of -$197859.0 in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities tumbled 1047.15% — and 2025, when it soared 97.71%.
- Tracing VNRX's Cash from Investing Activities over 5 years: stood at -$128572.0 in 2021, then sank by 350.14% to -$578752.0 in 2022, then soared by 46.66% to -$308722.0 in 2023, then jumped by 35.91% to -$197859.0 in 2024, then surged by 94.46% to -$10967.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$10967.0 (Q4 2025), -$76783.0 (Q2 2025), and -$1808.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Volitionrx | 1.13 Mn | -1.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10,967.00 |
| Dec 31, 2025 | -10,967.00 |
| Jun 30, 2025 | -76,783.00 |
| Jun 30, 2025 | -76,783.00 |
| Mar 31, 2025 | -1,808.00 |
| Mar 31, 2025 | -1,808.00 |
| Dec 31, 2024 | -197,859.00 |
| Dec 31, 2024 | -197,859.00 |
| Sep 30, 2024 | -136,737.00 |
| Sep 30, 2024 | -136,737.00 |
| Jun 30, 2024 | -160,447.00 |
| Jun 30, 2024 | -160,447.00 |
| Mar 31, 2024 | -78,809.00 |
| Mar 31, 2024 | -78,809.00 |
| Dec 31, 2023 | -308,722.00 |
| Dec 31, 2023 | -308,722.00 |
| Sep 30, 2023 | -273,041.00 |
| Sep 30, 2023 | -273,041.00 |
| Jun 30, 2023 | -301,394.00 |
| Jun 30, 2023 | -301,394.00 |